辨经论治:针刺带脉治疗高位腰椎间盘突出症临床疗效观察

注册号:

Registration number:

ITMCTR2100004414

最近更新日期:

Date of Last Refreshed on:

2020-11-04

注册时间:

Date of Registration:

2020-11-04

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

辨经论治:针刺带脉治疗高位腰椎间盘突出症临床疗效观察

Public title:

Treatment based on Meridional differentiation: Observation of clinical curative effect of acupuncture with pulse on high lumbar intervertebral disc herniation

注册题目简写:

English Acronym:

研究课题的正式科学名称:

常州市卫生健康委员会——常州市卫生健康青苗人才培养工程

Scientific title:

Changzhou Municipal Health Qing Miao talent training Program

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000039657 ; ChiMCTR2100004414

申请注册联系人:

李晗

研究负责人:

李晗

Applicant:

Han Li

Study leader:

Han Li

申请注册联系人电话:

Applicant telephone:

+86 13776897610

研究负责人电话:

Study leader's telephone:

+86 13776897610

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

long-1987@126.com

研究负责人电子邮件:

Study leader's E-mail:

long-1987@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

江苏省常州市天宁区和平北路25号

研究负责人通讯地址:

江苏省常州市天宁区和平北路25号

Applicant address:

25 Heping Road North, Tianning District, Changzhou, Jiangsu

Study leader's address:

25 Heping Road North, Tianning District, Changzhou, Jiangsu

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南京中医药大学常州附属医院常州市中医医院

Applicant's institution:

Changzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013/8/26 0:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南京中医药大学常州附属医院常州市中医医院

Primary sponsor:

Changzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine

研究实施负责(组长)单位地址:

江苏省常州市天宁区和平北路25号

Primary sponsor's address:

25 Heping Road North, Tianning District, Changzhou, Jiangsu

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

常州

Country:

China

Province:

Jiangsu

City:

Changzhou

单位(医院):

南京中医药大学常州附属医院常州市中医医院

具体地址:

天宁区和平北路25号

Institution
hospital:

Changzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine

Address:

25 Heping Road North, Tianning District, Changzhou, Jiangsu

经费或物资来源:

常州市卫生健康委员会——常州市卫生健康青苗人才培养工程

Source(s) of funding:

Changzhou Municipal Health Qing Miao talent training Program

研究疾病:

高位腰椎间盘突出症

研究疾病代码:

Target disease:

High level lumbar disc keyboard herniation

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

本项研究提出针刺带脉治疗高位腰椎间盘突出症可以快速改善疼痛评分和临床症状,缩短诊疗时间,改善腰部活动功能的研究假说。通过本项研究拟证实针刺带脉治疗高位腰椎间盘突出症临床疗效的优势,为辨经论治学术思想的临床实践提供科学依据。

Objectives of Study:

This study proposes a hypothesis that acupuncture and pulse therapy for high lumbar disc herniation can rapidly improve the pain score and clinical symptoms, shorten the diagnosis and treatment time, and improve the lumbar movement function.This study is intended to prove the superiority of the clinical curative effect of acupuncture with veins in the treatment of high lumbar intervertebral disc protrusion, and to provide scientific basis for the clinical practice of the academic thought of meridian differentiation and treatment.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①符合高位腰椎间盘突出突出诊断标准; ②年龄18~70岁; ③男女不限; ④自愿参加试验并且签署知情同意书。

Inclusion criteria

1. Meet the diagnostic criteria of high lumbar disc herniation; 2. Age between 18 to 70 years; 3. Male or female; 4. Volunteer for the trial and sign informed consent.

排除标准:

①伴有骨折、结核、肿瘤等病变; ②合并严重心脑血管疾病; ③合并精神障碍疾病; ④严重自杀倾向; ⑤已接受其他相关治疗; ⑥常年服用各类镇痛药物; ⑦嗜酒及药物滥用者; ⑧妊娠或哺乳期妇女。

Exclusion criteria:

1. Accompanied by fracture, tuberculosis, tumor and other lesions; 2. Complicated with severe cardiovascular and cerebrovascular diseases; 3. Combined with mental disorders; 4. Severe suicidal attempt; 5. Receiving other relevant treatment; 6. Take all kinds of analgesics all year round; 7. Alcohol and drug abusers; 8. Pregnant or lactating women.

研究实施时间:

Study execute time:

From 2021-01-01

To      2023-12-31

征募观察对象时间:

Recruiting time:

From 2021-01-01

To      2023-06-30

干预措施:

Interventions:

组别:

口服药物组

样本量:

30

Group:

Drug group

Sample size:

干预措施:

口服双氯芬酸钠双释放肠溶胶囊

干预措施代码:

Intervention:

Take NAIDs drugs

Intervention code:

组别:

针刺膀胱经组

样本量:

30

Group:

Bladder meridian group

Sample size:

干预措施:

膀胱经针刺

干预措施代码:

Intervention:

Acupuncture at bladder meridian

Intervention code:

组别:

针刺带脉组

样本量:

30

Group:

Dai meridian group

Sample size:

干预措施:

带脉针刺

干预措施代码:

Intervention:

Acupuncture at Dai meridian

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

江苏

市(区县):

常州

Country:

China

Province:

Jiangsu

City:

Changzhou

单位(医院):

南京中医药大学常州附属医院常州市中医医院

单位级别:

三级甲等中医院

Institution/hospital:

Changzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

疼痛评价指标

指标类型:

主要指标

Outcome:

Pain assessment index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

功能评价指标

指标类型:

主要指标

Outcome:

Functional evaluation index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

症状改善时间窗

指标类型:

主要指标

Outcome:

Symptoms improvement time

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 70
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

我院GCP中心参与本项研究,通过电脑产生随机数字进行分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

The GCP Center of our hospital participated in this study and generated random Numbers by computer for grouping.

盲法:

研究应用盲法(数据采集者盲、数据评价者盲),研究中心采用隔离的治疗床进行治疗,尽可能避免患者之间的交流。此外,采用盲法疗效评价以及盲法统计分析,由不知分组的第三方完成,实行研究者、操作者、统计者三分离。

Blinding:

The study applied the blind method (data collector blindness, data evaluator blindness), and the research center used the isolated treatment bed for treatment, to avoid the communication between patients as far as possible.In addition, blind efficacy evaluation and blind statistical analysis were performed by an unknown third party, and the researchers, operators and statisticians were separated.

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据上传到ResMan临床试验公共管理平台 Clinical Trial Management Public Platform,http://www.medresman.org.cn。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The raw data was uploaded to Clinical Trial Management Public Platform of ResMan, http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1. 电子化数据管理 1.1 本次试验数据管理基于电子化数据管理系统 1.2 电子病例报告表(eCRF)构建 数据管理员根据研究方案、病例报告表构建eCRF。 1.3 权限分配 EDC系统的用户采取分级赋权的形式,系统管理员确认数据管理员的身份,数据管理员确认监查员、稽查员、申办者、各机构主要研究者的身份,各机构主要研究者确认本单位研究者、数据录入员、伦理委员会成员的身份,分级分别创建账号,授予不同权限访问EDC系统。 1.4 数据录入 数据录入及时、准确地将病例报告表中的数据录入eCRF。eCRF不作为原始记录,其内容源于“病例报告表”。 1.5 源数据现场核查(SDV) 监查员在各中心研究现场登录数据数据管理系统的数据监查端,100%的核对电子CRF数据与病例报告表等源数据的一致性,发现问题可随时在线发出疑问,数据录入员下载疑问,研究者给予解答,数据录入员直接在疑问管理界面更新数据。必要时监查员可以重复发出疑问。 1.6 数据锁定及导出 所有受试者完成试验,病例报告表全部录入系统,并经监查员审阅,数据管理员的审核无误后,由数据管理员对数据进行锁定。数据全部锁定后,由数据管理员将其导入到指定数据库,交统计人员进行统计分析。 2. 制定数据管理计划 2.1 数据管理计划由数据管理员撰写。 2.2 数据管理计划将作为整个数据管理过程的指导性文件,之后所有过程均应按照其中定义的时间与方法进行操作。 2.3 数据管理计划的内容包括 2.3.1 数据管理计划的管理,如所有权、封面规定、目录等; 2.3.2 研究的一般情况,如研究目的,研究的整体设计等; 2.3.3 数据管理工作的时间表。在此时间表中,每个环节的开始与完成时间都应有所体现,同时,该时间表应与整个临床试验的大时间表相互协调; 2.3.4 相关人员的职责规定,包括EDC系统管理员(Admin),项目数据管理员(DM),研究者(Ivestigator),数据录入员,监查员(CRA)等; 2.3.5 数据管理设计,包括数据库设计和逻辑核查设计; 2.3.6 用户与权限的分配; 2.3.7 数据处理规定; 2.3.8 数据质控; 2.3.9 数据库闭合; 2.3.10 数据安全保密措施; 2.3.11 EDC系统应急方案。 3. 数据管理设计 3.1 设计数据采集表格(病例报告表) 依据试验方案设计数据采集表格,并由研究项目组成员,包括主要研究者、监查员、数据管理员、统计学家及填写者(如CRC),从不同的视角对数据采集文件及其关联文件进行审查,使其满足不同成员的需求,增强其可用性,提高数据质量,减少后期的数据清理程序。 3.2 电子病例报告表(eCRF) 依据临床研究方案和病例报告表,在EDC数据管理系统中设计,由接受过EDC系统应用培训的数据管理员完成。 3.3 设计逻辑检查,包括系统自动逻辑检查与人工逻辑检查。 3.4 项目的系统测验 对构建的eCRF进行测试,保证此项目中所有的CRF都能够录入、保存、显示和导出,双份录入不一致性核对程序正常运行,所有的逻辑核查能正常运行,所有疑问能准确无误的发行、下载、更新和审核。 3.5 角色与权限分配 3.5.1 只给受过EDC系统培训的相关人员创建账号; 3.5.2 各研究机构的账号只能访问本机构的受试者,必要时给予特定角色(如主要研究者)共享受试者功能,以便及时了解各研究中心受试者情况; 3.5.3 创建的账号分别归类于各类角色,每个角色都有其特定的权限。以下是各种角色对EDC系统的操作权限: 1) 主要研究者:查阅本机构病例的电子CRF(超文本格式,可查看操作痕迹)、查看整个研究与本机构的研究进度、了解整个研究与本机构的不良事件与合并用药情况; 2) 研究者:查询本人负责观察的病例数据、相关疑问及其解决情况、了解整个研究与本机构的不良事件与合并用药情况; 3) 数据录入员:数据录入、下载疑问、更新数据、查阅本机构病例的电子CRF(超文本格式,可看到操作痕迹); 4) 监查员:各中心的理化检查正常值维护、查阅研究所有病例的电子CRF(超文本格式,可看到操作痕迹)、发出疑问、数据审阅、查阅不良事件与合并用药情况、查看整个研究与各机构的研究进展; 5) 数据管理员:设计逻辑核查、构建eCRF、查阅研究所有病例的电子CRF(超文本格式,可看到操作痕迹)、发出疑问、数据审核、数据锁定、数据导出; 6) 申办者:查阅研究所有病例的电子CRF、查看操作痕迹、查看不良事件与合并用药情况、查看整个研究与各机构的研究进度; 7) 伦理委员会:查阅研究所有病例的电子CRF、查看操作痕迹、查看不良事件与合并用药情况、查看整个研究与各机构的研究进度。 4. EDC系统的数据录入和核查 4.1 数据录入员在操作前必须经过相关培训; 4.2 输入用户名、密码、附加密码后进入系统; 4.3 EDC系统账号和密码是保密的,要遵循相关保密条例; 4.4 数据录入员负责按随访时点报告研究数据,便于监查员和数据管理员及时对数据进行同步审阅并对可疑的数据产生疑问,以便有疑问数据得到及时正确的答复; 4.5 数据录入员在录入数据后,可点击“保存”来保存已经录入的数据,在确认当前页面录入完成,不再进行修改后,点击“提交”。提交后页面的编辑权限被取消,如需要补录或修改数据,可与数据管理员联系,通过网络留言申请,后者有权开启需要补录页面的编辑权限,或通过疑问解决来修改数据。使用在线的方式完成双份录入不一致数据的确认。 4.6 数据录入员在提交数据后,系统会对录入数据进行逻辑检查,和CRA进行人工检查、源数据现场核查(SDV),发现问题即发行疑问,由数据人员定期登录系统,下载本机构的疑问生成数据澄清表(DCF)。 4.7 研究者/录入员在疑问表中对疑问内容进行答复,数据只在DCF上修改,DCF作为源文件保存,录入员在系统中在线更新数据。 4.8 监查员在录入员答复疑问后,对疑问内容进行确认,确认后,审核通过。 4.9 数据管理员对试验中的疑问进行检查,确认是否所有疑问都已解决。 4.10 监查员定期访视研究机构,登录EDC系统,100%的核对电子CRF数据与病例报告表等源数据的一致性。 5. 数据库关闭及锁定 5.1 在得到临床研究者和监查员的通知,每一味受试者数据都已全部录入到EDC系统并得到处理,包括不良事件追踪检查的数据,所有疑问都已得到解决并更新至数据库,编码目录的完整性与一致性已审核,数据管理员已对数据进行盲态审核,盲态审核报告已得到所有相关人员的签署后,数据管理员提出数据库关闭申请,一旦获得批准,取消数据库编辑权限,记录数据库锁定的时间点,作为编辑权限被取消的证据。 5.2 数据管理员将所有的试验数据导出数据库文件,交统计方进行统计分析。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1. Electronic data management 1.1 Data management of this experiment is based on the electronic data management system 1.2 Construction of electronic Case Report Form (eCRF) The data manager builds eCRF based on the study protocol and case report form. 1.3 Permission Assignment EDC system users to take the form of hierarchical empowerment, system administrators to confirm the identity of the data managers, data managers confirm the arbitrator, inspector, the sponsor, the identity of the principal investigator agencies, institutions mainly the researchers confirmed that the unit researchers, data operator, the identity of the ethics committee members, hiberarchy, your account was created with different permissions to access the EDC system. 1.4 Data entry Data entry Timely and accurately enter eCRF data into the case report form.The eCRF is not regarded as the original record, and its content is derived from the "case Report Form". 1.5 Source data On-site Verification (SDV) Arbitrator in the center of the research site login data monitoring data management system of data, 100% of the check electronic CRF form data and cases such as the source data consistency, found that the problem may at any time online question, download data operator question, the researchers offer solutions, data operator directly update the data in question management interface.If necessary, the supervisor may repeat the question. 1.6 Data locking and export All subjects have completed the test, and the case report form has been input into the system and reviewed by the supervisor. After the data manager's review is correct, the data manager will lock the data.After all the data are locked, the data manager will import them into the specified database and submit them to statisticians for statistical analysis. 2. Develop a data management plan 2.1 The data management plan is written by the data manager. 2.2 The data management plan will serve as a guiding document for the entire data management process, and thereafter all processes shall operate according to the time and method defined therein. 2.3 The contents of the data management plan include 2.3.1 Management of data management plan, such as ownership, cover provisions, catalogues, etc.; 2.3.2 General conditions of the study, such as the purpose of the study and the overall design of the study; 2.3.3 Schedule of data management.The timing of commencement and completion of each segment should be reflected in this schedule, which should be coordinated with the overall clinical trial schedule; 2.3.4 Responsibilities of relevant personnel, including EDC system administrator (Admin), project data Administrator (DM), researchers (Ivammonator), data log-in workers, monitor (CRA), etc.; 2.3.5 Data management design, including database design and logic check design; 2.3.6 Allocation of users and permissions; 2.3.7 Provisions on data processing; 2.3.8 Data quality control; 2.3.9 Database closure; 2.3.10 Data security and confidentiality measures; 2.3.11 Emergency plan of EDC system. 3. Data management design 3.1 Design data Collection Form (Case Report Form) According to the test scheme design data collection form, and by the study team members, including the main researchers, arbitrator, data managers, a statistician and fill in the (CRC), from a different perspective to review of data acquisition and its associated files, make it meet the needs of different members, enhance its availability, improve the quality of data, reduce the data cleaning program later. 3.2 Electronic Case Report Form (eCRF) According to the clinical study protocol and case report form, it is designed in the EDC data management system and completed by the data manager who has received the EDC system application training. 3.3 Design logic check, including automatic system logic check and manual logic check. 3.4 System test of the project Test the built eCRF to ensure that all CRFS in the project can be entered, saved, displayed and exported, the double-entry inconsistency checker runs normally, all logic checks can run normally, and all questions can be correctly released, downloaded, updated and reviewed. 3.5 Role and permission assignment 3.5.1 Only create accounts for relevant personnel who have received EDC system training; 3.5.2 The account of each research institution can only access the subjects of the institution. If necessary, specific roles (such as the principal investigator) shall be given to share the subject function, so as to timely understand the subjects of each research center; 3.5.3 The accounts created are classified into various roles, and each role has its own specific permissions.The following are the permissions of various roles to operate on the EDC system: 1) Main investigator: check the electronic CRF (hypertext format, operation traces can be checked) of the cases of the institution, check the progress of the whole study and the institution, and understand the adverse events and combined medication of the whole study and the institution; 2) Investigator: To inquire the case data, relevant questions and solutions of my observation, and to understand the adverse events and combined medication of the whole study and the institution; 3) Data entry clerk: data entry, download questions, update data, and consult the electronic CRF of the institution's medical cases (hypertext format, operation traces can be seen); 4) Inspectors: maintain the normal value of physical and chemical examination in each center, check the electronic CRF of all cases studied (hypertext format, operation traces can be seen), ask questions, review data, check the adverse events and combined drug use, and check the research progress of the whole study and various institutions; 5) Data manager: Design logic verification, build eCRF, check the electronic CRF (hypertext format, visible operation traces) of all cases in the study, question raising, data review, data locking and data export; 6) Sponsor: check the electronic CRF of all study cases, check the operation traces, check the adverse events and combined medication, check the whole study and the progress of each institution; 7) Ethics committee: check the electronic CRF of all cases studied, check the operation traces, check the adverse events and combined medication, and check the whole study and the research progress of each institution. 4. Data entry and verification of EDC system 4.1 Data entry personnel must undergo relevant training before operation; 4.2 Enter the system after inputting user name, password and additional password; 4.3 The EDC system account and password are confidential and shall follow the relevant confidentiality regulations; 4.4 The data entry clerk is responsible for reporting the research data according to the follow-up points, so as to facilitate the monitor and data manager to synchronously review the data in a timely manner and to have questions about the suspicious data, so as to get a timely and correct reply to the questioned data; 4.5 After data entry, the data entry clerk can click "Save" to save the entered data, and click "Submit" after confirming that the current page entry is complete and no modification is required.After submission, the editing permission of the page is cancelled. If you need to supplement or modify the data, you can contact the data administrator and apply through the network message. The latter has the right to open the editing permission of the page requiring supplement or modify the data through question solving.Use the online method to confirm the double inconsistencies. 4.6 After the data entry clerk submits the data, the system will conduct logical check on the input data, manual check with CRA, and on-site source data verification (SDV). When problems are found, questions will be released. The data clerk will log into the system regularly, download the questions of the institution, and generate data clarification table (DCF). 4.7 The researcher/keylogger answers the questions in the query table, and the data is only modified on DCF, which is saved as the source file, and the keylogger updates the data online in the system. 4.8 After the examiner replies to the questions, the contents of the questions shall be confirmed by the examiner. After the confirmation, the questions shall be reviewed and approved. 4.9 The data manager shall check the questions in the test to confirm whether all the questions have been solved. 4.10 The inspector visits the research institutions regularly, logs in the EDC system, and verifies the consistency between the electronic CRF data and the case report form and other source data by 100%. 5. Database closing and locking 5.1 notice, by the clinical researchers and cooperates each blindly data subjects have all keyed to the EDC system and dealt with, including adverse events track inspection data, all questions have been solved and updates to the database, code directory for completeness and consistency has audit, data managers have to blind state audit data, blind state audit report has been all after the signing of the relevant personnel, data managers apply for shutdown, once approved, cancel the database edit permissions, record database locking point in time, as evidence of edit permissions were canceled. 5.2 The data manager will export all the test data to the database file and submit it to the statistician for statistical analysis.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统